The final collegium of the Ministry of Health of the Russian Federation took place on April 12, 2017. The managers of healthcare and collegium participants made program reports. The total work of the healthcare system for 2016 was summed up and the main directions of its further development are outlined.
In difficult economic conditions, the health care system managed to ensure the required dynamics of reduction of death rates from individual causes and increase in wages for medical workers; the availability of free medical care for the population is preserved; a set of measures were implemented to restructure the system of medical care and increase its effectiveness; the system of compulsory medical insurance has been modernized. However, many important issues of improving the organization, management and financial provision of the medical care system remained unresolved.
Since 2013, the application of the per capita method of payment for primary health care for medical organizations with attached populations has become a mandatory normative requirement. The article examines the experience of using per capita financing in the USSR and Russia and features the current organizational and economic mechanism of per capita financing.
Domestic healthcare in 1993 moved to a new organizational and economic model – «Compulsory Medical Insurance». The author of the MHI system in Russia, the first director of the Federal Fund for Compulsory Medical Insurance, Grishin V.V., expressed his opinion on fulfilling the expectations related to the rejection of the state model of health management.
The constant increase in health care costs associated with the emergence of new medical technologies and drugs, changes in the structure of morbidity and demographic problems, is a common trend for the developed countries of the world. The article considers the main approaches to assessing the effectiveness of health care.
The issues of economic efficiency of the medical organization are the most important components of modern approaches to health management. The article gives recommendations of the leading specialist in Russia on methods of cost allocation in medical organizations.
Health care providers are constantly confronted with the question of the choice of medicinal drugs (MD) in the process of medicinal provision of the population, incl. When forming restrictive lists. To date, the use of methods of pharmacoeconomic analysis is one of the tools that will enable decisionmakers in health policy to make scientifically-sound choices when drawing up such lists of MDs and, as a whole, within the framework of implementing the drug provision strategy for the population. This article presents such an opportunity for pharmacoeconomics in this issue as the use of the indicator of added years of life with regard to its quality (QALY).
